Surgical difficulty and factors associated with conversion to thoracotomy after neoadjuvant chemoimmunotherapy for non-small cell lung cancer: a single- center retrospective study
This single-center retrospective study of 101 NSCLC patients found that higher clinical T stage and complex hilar anatomy (specifically pulmonary artery and bronchial relationships) on preoperative CT are key predictors of conversion from VATS to thoracotomy following neoadjuvant chemoimmunotherapy, a conversion that increases operative time and blood loss but should be viewed as a safety strategy rather than surgical failure.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Lung cancer remains one of the most formidable challenges in modern medicine, particularly when the disease is caught early enough to be removed surgically. For years, doctors have relied on a combination of chemotherapy and newer drugs that train the body's immune system to attack cancer cells before an operation. This pre-treatment strategy, known as neoadjuvant chemoimmunotherapy, often shrinks tumors significantly, making them appear easier to remove. However, a paradox exists: while the tumor may get smaller on a scan, the tissue around it can become scarred, inflamed, and stuck together. This internal landscape, altered by the treatment itself, can make the actual surgery much harder than expected. Surgeons often begin with a minimally invasive approach, using small incisions and cameras to operate, but sometimes the complexity of the scar tissue forces them to switch to a large, open chest incision to ensure the patient's safety. Understanding exactly which patients face this difficult transition is crucial for planning the best possible care.
A team of researchers at the Affiliated Hospital of Zunyi Medical University in China set out to understand why this switch happens. They looked back at the records of 101 patients who had undergone this specific pre-treatment for non-small cell lung cancer and then had surgery. In their study, about two-thirds of the patients, specifically 67 individuals, had to switch from the minimally invasive camera technique to an open chest surgery, a procedure called a thoracotomy. The remaining 34 patients were able to complete their surgery using the smaller, less invasive method. The researchers wanted to know what clues visible on pre-operative CT scans could predict who would need that larger incision. They were not just looking at the size of the tumor, but specifically at how the cancer interacted with the delicate structures of the lung, such as the main arteries and airways, and how much scar tissue had formed in the area where the lung connects to the rest of the body.
The investigation revealed that the difficulty of the surgery was not just about how big the tumor was, but where it sat and what it was touching. The most powerful predictor was the stage of the cancer before treatment began; patients with more advanced local disease were far more likely to require the open procedure. However, the study found that even more specific details mattered. The researchers developed a way to grade how closely the tumor or swollen lymph nodes touched the main pulmonary artery and the main airway. They found that as the contact between the tumor and these vital structures increased, the likelihood of needing to switch to an open surgery rose sharply. For instance, when the tumor merely touched the artery, the chance of a difficult surgery was moderate, but when the tumor wrapped around the artery or caused it to narrow, the need for an open incision became almost certain. Similarly, the degree of contact with the airway was a strong indicator of surgical complexity.
Interestingly, the amount of general scarring or fibrosis seen on the scans did not independently predict whether a surgeon would have to switch to an open approach. This suggests that the specific geometry of how the tumor clings to the blood vessels and airways is a more critical factor than the general presence of scar tissue. The study also highlighted that when a switch to an open surgery was necessary, it was not a sign of failure, but rather a safety decision. Patients who underwent the conversion had longer operations and lost more blood, which is expected when a surgeon must open the chest to gain better visibility and control in a difficult situation. Yet, the study found no significant difference in the success of removing the cancer completely or in the rate of lung complications between those who stayed with the minimally invasive method and those who switched.
The researchers concluded that looking closely at the relationship between the tumor and the major blood vessels and airways on a CT scan can help surgeons prepare for the challenges ahead. If a tumor is deeply entangled with these structures, a surgeon might anticipate a longer, more complex operation or plan for an open approach from the start. The study emphasizes that converting to an open surgery should be viewed as a prudent safety strategy to ensure the cancer is removed cleanly and the patient remains safe, rather than as a mistake or a failure of the minimally invasive technique. By understanding these anatomical relationships, medical teams can better plan their approach, ensuring that the decision to switch methods is made with confidence and clarity, prioritizing the patient's well-being above the method of entry.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.